Publication Name	世界华人消化杂志
手稿编号	36353
手稿来源省、自治区或特别行政区	陕西省

Received	2018-09-07 03:51
Peer-Review Started	2018-09-07 07:33
To Make the First Decision	2018-10-08 02:54
Return for Revision	2018-10-10 01:42
修回稿	2018-10-17 05:55
Second Decision	2018-10-29 07:26
期刊总编辑接受
公司总编辑接受	2018-10-30 01:58
预出版	2018-10-30 01:58
缴纳版面费
Edit the Manuscript by Language Editor
排版	2018-12-06 09:44
在线出版	2018-12-08 10:24

ISSN	1009-3079 (print) and 2219-2859 (online)
开放获取	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
版权	© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
网址	http://www.wjgnet.com

专业类型	消化肿瘤学
手稿栏目类型	文献综述
文章标题	肝细胞癌的分子靶向治疗
手稿来源	约稿
所有作者列表	石娟娟, 党双锁
基金项目及其编号
通讯作者	党双锁, 博士, 教授, 研究员, 主任医师, 710004, 西安市新城区西五路157号, 陕西省西安交通大学第二附属医院感染科. dang212@126.com
关键词	肝细胞癌; 分子机制; 靶向治疗; 靶向药物
核心内容提要	肝细胞癌(hepatocellular carcinoma, HCC)死亡率居所有肿瘤的第二位, 且近年在我国有上升趋势. HCC分子靶向药物的使用和研究, 开启了HCC治疗方法的新阶段.
出版日期	2018-12-08 10:24
引文著录	石娟娟, 党双锁. 肝细胞癌的分子靶向治疗. 世界华人消化杂志 2018
URL	https://www.wjgnet.com/1009-3079/full/v26/i34/2008.htm
DOI	https://dx.doi.org/10.11569/wcjd.v26.i34.2008

Full Article (PDF)	WCJD-26-2008.pdf
补充材料	36353-补充材料-revision.jpg
审稿意见	WCJD-36353-Peer-review(s).pdf
科学编辑工作清单	WCJD-36353-Scientific editor work list.pdf